tailieunhanh - Prognostic analysis of patients with nonsmall cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases

In 1997, the Radiation Therapy Oncology Group (RTOG) put forward the recursive partitioning analysis classification for the prognosis of brain metastases (BMs), but this system does not take into account the epidermal growth factor receptor (EGFR) mutations. The aim of the study is to assess the prognosis of patients with EGFRmutated non-small cell lung cancer (NSCLC) and BMs in the era of tyrosine kinase inhibitor (TKI) availability. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN